166 related articles for article (PubMed ID: 33222966)
21. Efficacy of cranial electrotherapy stimulation for neuropathic pain following spinal cord injury: a multi-site randomized controlled trial with a secondary 6-month open-label phase.
Tan G; Rintala DH; Jensen MP; Richards JS; Holmes SA; Parachuri R; Lashgari-Saegh S; Price LR
J Spinal Cord Med; 2011; 34(3):285-96. PubMed ID: 21756567
[TBL] [Abstract][Full Text] [Related]
22. An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.
Wilsey B; Marcotte TD; Deutsch R; Zhao H; Prasad H; Phan A
J Pain; 2016 Sep; 17(9):982-1000. PubMed ID: 27286745
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of spinal cord injury induced edema and neuropathic pain: expression of multiple isoforms of wnk1.
Ahmed MM; Lee H; Clark Z; Miranpuri GS; Nacht C; Patel K; Liu L; Joslin J; Kintner D; Resnick DK
Ann Neurosci; 2014 Jul; 21(3):97-103. PubMed ID: 25206073
[TBL] [Abstract][Full Text] [Related]
24. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury.
Levendoglu F; Ogün CO; Ozerbil O; Ogün TC; Ugurlu H
Spine (Phila Pa 1976); 2004 Apr; 29(7):743-51. PubMed ID: 15087796
[TBL] [Abstract][Full Text] [Related]
25. Crossing the Chloride Channel: The Current and Potential Therapeutic Value of the Neuronal K
Tillman L; Zhang J
Biomed Res Int; 2019; 2019():8941046. PubMed ID: 31240228
[TBL] [Abstract][Full Text] [Related]
26. Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress.
Hu D; Yu ZL; Zhang Y; Han Y; Zhang W; Lu L; Shi J
Sci Rep; 2017 Sep; 7(1):11878. PubMed ID: 28928398
[TBL] [Abstract][Full Text] [Related]
27. Administration of ONO-2506 suppresses neuropathic pain after spinal cord injury by inhibition of astrocytic activation.
Ishiguro H; Kaito T; Hashimoto K; Kushioka J; Okada R; Tsukazaki H; Kodama J; Bal Z; Ukon Y; Takenaka S; Makino T; Sakai Y; Yoshikawa H
Spine J; 2019 Aug; 19(8):1434-1442. PubMed ID: 30974239
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
Han ZA; Song DH; Oh HM; Chung ME
Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
[TBL] [Abstract][Full Text] [Related]
29. Prochlorperazine Increases KCC2 Function and Reduces Spasticity after Spinal Cord Injury.
Liabeuf S; Stuhl-Gourmand L; Gackière F; Mancuso R; Sanchez Brualla I; Marino P; Brocard F; Vinay L
J Neurotrauma; 2017 Dec; 34(24):3397-3406. PubMed ID: 28747093
[TBL] [Abstract][Full Text] [Related]
30. Mental Imagery as a Rehabilitative Therapy for Neuropathic Pain in People With Spinal Cord Injury: A Randomized Controlled Trial.
Kaur J; Ghosh S; Sahani AK; Sinha JK
Neurorehabil Neural Repair; 2020 Nov; 34(11):1038-1049. PubMed ID: 33040678
[TBL] [Abstract][Full Text] [Related]
31. Ultramicronized palmitoylethanolamide in spinal cord injury neuropathic pain: a randomized, double-blind, placebo-controlled trial.
Andresen SR; Bing J; Hansen RM; Biering-Sørensen F; Johannesen IL; Hagen EM; Rice ASC; Nielsen JF; Bach FW; Finnerup NB
Pain; 2016 Sep; 157(9):2097-2103. PubMed ID: 27227691
[TBL] [Abstract][Full Text] [Related]
32. rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury.
Nardone R; Höller Y; Langthaler PB; Lochner P; Golaszewski S; Schwenker K; Brigo F; Trinka E
Spinal Cord; 2017 Jan; 55(1):20-25. PubMed ID: 27241450
[TBL] [Abstract][Full Text] [Related]
33. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
Kahle KT; Staley KJ
Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic restoration of spinal inhibition via druggable enhancement of potassium-chloride cotransporter KCC2-mediated chloride extrusion in peripheral neuropathic pain.
Kahle KT; Khanna A; Clapham DE; Woolf CJ
JAMA Neurol; 2014 May; 71(5):640-5. PubMed ID: 24615367
[TBL] [Abstract][Full Text] [Related]
35. An unusual presentation of neuropathic pain following cervical spinal cord injury: a case report.
Chang MC; Boudier-Revéret M; Choo YJ; Hsiao MY
BMC Neurol; 2020 Feb; 20(1):61. PubMed ID: 32070321
[TBL] [Abstract][Full Text] [Related]
36. Acute spinal cord injury (SCI) transforms how GABA affects nociceptive sensitization.
Huang YJ; Lee KH; Murphy L; Garraway SM; Grau JW
Exp Neurol; 2016 Nov; 285(Pt A):82-95. PubMed ID: 27639636
[TBL] [Abstract][Full Text] [Related]
37. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial.
Tai Q; Kirshblum S; Chen B; Millis S; Johnston M; DeLisa JA
J Spinal Cord Med; 2002; 25(2):100-5. PubMed ID: 12137213
[TBL] [Abstract][Full Text] [Related]
38. Analgesia-enhancing effects of repetitive transcranial magnetic stimulation on neuropathic pain after spinal cord injury:An fNIRS study.
Sun X; Long H; Zhao C; Duan Q; Zhu H; Chen C; Sun W; Ju F; Sun X; Zhao Y; Xue B; Tian F; Mou X; Yuan H
Restor Neurol Neurosci; 2019; 37(5):497-507. PubMed ID: 31381538
[TBL] [Abstract][Full Text] [Related]
39. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
[TBL] [Abstract][Full Text] [Related]
40. Examining the Time to Therapeutic Effect of Pregabalin in Spinal Cord Injury Patients With Neuropathic Pain.
Cardenas DD; Emir B; Parsons B
Clin Ther; 2015 May; 37(5):1081-90. PubMed ID: 25850879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
